Literature DB >> 20472634

Heparin-induced thrombocytopenia.

Joseph W Szokol1.   

Abstract

Heparin-induced thrombocytopenia (HIT) is an antibody-mediated reaction caused by exposure to heparin that can lead to devastating thrombotic complications. HIT usually occurs 5 to 10 days after exposure to heparin but can happen more rapidly to patients who are reexposed to heparin within 100 days. The hallmark of this disorder is a sudden drop in platelet count of greater than 50%. Once HIT is suspected the heparin must be immediately discontinued and an anticoagulant (direct thrombin inhibitor or heparinoid) started. For patients presenting for cardiac surgery and cardiopulmonary bypass that have a history of HIT and positive antibodies a direct thrombin inhibitor such as lepirudin, argatroban or bivalirudin must be used in lieu of heparin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472634     DOI: 10.1177/1089253210362795

Source DB:  PubMed          Journal:  Semin Cardiothorac Vasc Anesth        ISSN: 1089-2532


  2 in total

1.  Two cases of heparin-induced thrombocytopenia after off-pump coronary artery bypass surgery.

Authors:  Kaushalendra Rathore; Evan Boon; Alex Wilson; Mark Newman
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-01-15

2.  Successful Use of Alternative Anticoagulants in the Management of Heparin-induced Thrombocytopenia with Thrombotic Complications: Report of 5 cases and review of literature.

Authors:  Salam Alkindi; Owen P Smith; Helen Enright
Journal:  Sultan Qaboos Univ Med J       Date:  2011-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.